Feyi Olopade Ayodele


Feyi Olopade Ayodele is CancerIQ’s co-founder and CEO. In this role, Feyi is leading CancerIQ’s bold vision to end cancer as we know it by empowering providers and health systems to improve access to the latest innovations in early cancer detection and prevention. CancerIQ makes it easy to gather comprehensive patient data, automatically map it to the latest evidence-based guidelines, and expand access to cutting-edge care. Under Feyi’s leadership, CancerIQ has grown its provider network to over 200 locations across the county and established a robust ecosystem of leading diagnostic and genomics testing

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved